Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

A new systematic review and meta-analysis published in the Clinical Nutrition ESPEN revealed promising outcomes for the ...

HFpEF outcomes were improved with semaglutide, compared with placebo, among patients with obesity-related HFpEF and type 2 diabetes.

A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...

You can rotate injections between your stomach, upper arm, and thigh. Semaglutide is a prescription type 2 diabetes medication. It’s sold under the brand names Wegovy and Ozempic. You’ll need ...

A recent study has found that the diabetes drug tirzepatide helps people with type 2 diabetes lower their blood sugar and ...

The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...

Oral semaglutide administered via the RaniPill® HC (RT-116) demonstrated comparable bioavailability, pharmacokinetics and ...